Inflammation
📧 Sign up to get email alerts when something new happens for Inflammation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-10Clinical Trial Update: Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease [NA]
The clinical trial evaluating exercise rehabilitation efficacy in Veterans with peripheral artery disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: Combining HIIT and n-3 PUFA Supplementation to Reduce Inflammation and Improve Metabolic Health (HIIT&PUFA) [NA]
The HIIT&PUFA trial examining high-intensity interval training plus omega-3 fatty acid supplementation for obesity-related inflammation and …
-
CLINICAL_TRIALS withdrawal · 2024-07-30Clinical Trial Update: Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
The study evaluating erythrocyte membrane integrity after cardiac surgery was withdrawn; sponsored by Anthea Hospital Bari.
-
CLINICAL_TRIALS withdrawal · 2024-05-02Clinical Trial Update: Inflammatory Cell Trafficking After Myocardial Infarction [NA]
A clinical trial investigating inflammatory cell trafficking after myocardial infarction has been withdrawn from the registry. The sponsor l…
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2008-03-07Clinical Trial Update: Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating sub-Tenon's injection of Triamcinolone and Ciprofloxacin in a controlled-release system for cataract s…